Edwards Lifesciences (EW) Long-Term Debt Issuances (2009 - 2021)

Edwards Lifesciences' Long-Term Debt Issuances history runs 11 years deep, the most recent figure standing at -$8.8 million for Q3 2021.

• In Q3 2021, Long-Term Debt Issuances fell 617.65% year-over-year to -$8.8 million; the TTM figure through Jun 2022 stood at -$8.8 million (down 144.9% YoY), while the FY2021 annual figure was $5.2 million, down 67.9% from the prior year.
• Long-Term Debt Issuances was -$8.8 million for Q3 2021 at Edwards Lifesciences, down from $9.5 million in the prior quarter.
• In the past five years, Long-Term Debt Issuances ranged from a high of $608.0 million in Q2 2017 to a low of -$8.8 million in Q3 2021.
• Historically, Long-Term Debt Issuances has averaged $86.4 million across 5 years, with a median of $4.5 million in 2021.
• The sharpest annual moves came in 2017 and 2021: Long-Term Debt Issuances surged 9706.45% in 2017, then slumped 617.65% in 2021.
• A 5-year view of Long-Term Debt Issuances shows it stood at $5.4 million in 2017, then plunged by 70.37% to $1.6 million in 2018, then surged by 331.25% to $6.9 million in 2019, then slumped by 43.48% to $3.9 million in 2020, then tumbled by 325.64% to -$8.8 million in 2021.
• The last three Long-Term Debt Issuances figures came in at -$8.8 million (Q3 2021), $9.5 million (Q2 2021), and $4.5 million (Q1 2021), per Business Quant data.